RNL-Astrostem®, adipose-derived mesenchymal stem cells for treatment of Romberg's disease
RNL-Astrostem® are autologous adipose-derived mesenchymal stem cells (Adipose-MSCs) used for treatment of a wide range of diseases. The purpose of this study is to assess the efficacy and safety of autologous transplantation of adipose-MSCs in patients with progressive hemifacial atrophy (Romberg's disease).
Read More
Product Information for
RNL-Astrostem®, adipose-derived mesenchymal stem cells for treatment of Romberg's disease